BVS FY 2025 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

FY 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$568M-0.9% YoY

Gross Profit

$382M67.3% margin

Operating Income

$59M10.3% margin

Net Income

$23M4.0% margin

EPS (Diluted)

$0.33

Cash Flow

Operating Cash Flow

$74M

Free Cash Flow

$71M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$684M

Total Liabilities

$455M

Stockholders' Equity

$184M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$568M	$573M	-0.9%
Gross Profit	$382M	$388M	-1.5%
Operating Income	$59M	-$12M	+588.7%
Net Income	$23M	-$34M	+167.8%